Collaborations, Competitor News, Oncology, Product Updates

ConcertAI Announces Integration of TeraRecon, Accelerating Enterprise AI Deployment into Clinical Practice and Broadening Precision Oncology Research Network

Posted on

CAMBRIDGE, Mass. and DURHAM, N.C., Nov. 9, 2021 /PRNewswire/ — ConcertAI, LLC (ConcertAI), a leader in enterprise AI and RWD solutions for life science companies and healthcare providers, announced today the integration of TeraRecon as a ConcertAI company. The combination is unprecedented in bringing electronic medical records, genomic data, and medical image data into one…

Clinical Trials, Collaborations, Competitor News, Data Partnership, Oncology

Kronos Bio and Tempus Announce Multi-Year Collaboration to Provide Kronos Bio With Access to Tempus’ Platform

Posted on

Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, and Tempus, a leader in artificial intelligence and precision medicine, today announced a multi-year collaboration that provides Kronos Bio with access to Tempus’ real-world genomic and transcriptomic data and data analytics tools. Under…

Government/Regulatory, Industry News, Oncology, RWE Study

Clinical Cancer Research Publishes a Systematic Review of Regulatory Real-World Evidence in Successful Oncology Product Approvals

Posted on

BOSTON, Nov. 5, 2021 /PRNewswire/ — Analysis Group, a global leader in health economics and outcomes research (HEOR) and regulatory epidemiology, today announced the publication of research examining the US Food and Drug Administration’s (FDA’s) commentary on the use of real-world evidence (RWE) in successful oncology product approvals between 2015 and 2020. The…

Collaborations, Partner and Collaborator News

Palantir and AlixPartners Join Forces to Help Clients Unlock the Value of Data

Posted on

NEW YORK & DENVER–(BUSINESS WIRE)–AlixPartners, the global consulting firm, and Palantir Technologies, a leading builder of operating systems for the modern enterprise, today announced a strategic partnership designed to unlock and accelerate their clients’ use of data to drive outsized results. The partnership will combine AlixPartners’s world-renowned strategic and operational…

Collaborations, Competitor News, Data Partnership

COEUS Partners with Datavant to Advance Outcomes-based Contracting and Commercial Insights

Posted on

DEVON, Penn., Nov. 2, 2021 — COEUS Holdings and its subsidiaries, together a leading health outcomes, contracting and commercial insights consulting firm, today announced a strategic partnership with Datavant, the leader in privacy-compliant health data exchange, to advance their COEBRA™ platform for biopharmaceutical value-based contracting adjudication and commercial insight generation. COEUS HealthCare’s COEBRA™…

Collaborations, Competitor News, Data Partnership, Oncology

Kinnate Biopharma Inc. in Collaboration with Guardant Health Announces Initial Findings from BRAF Kinase Alteration Genomic Landscape and Real-World Clinical Outcomes Study

Posted on

SAN FRANCISCO and SAN DIEGO, Nov. 01, 2021 (GLOBE NEWSWIRE) — Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers, today announced a collaboration with Guardant Health, a leading precision oncology company, focused on…

Clinical Trials, Collaborations, Competitor News, Fundraising/IPO, Government/Regulatory

Cardinal Health Awarded FDA Funding to Assess Real World Evidence Results Against Clinical Trials

Posted on

DUBLIN, Ohio, Oct. 28, 2021 /PRNewswire/ — Cardinal Health (NYSE: CAH) announced today it has been awarded a $750,000 contract by the U.S. Food and Drug Administration (FDA) to implement an 18-month real world evidence (RWE) study as part of the agency’s efforts to advance the applicability of RWE in regulatory decision-making. The funding, which will…

Competitor News, HR

HealthVerity broadens appeal for its IPGE Platform with key executive hires

Posted on

PHILADELPHIA, Oct. 28, 2021 /PRNewswire/ — HealthVerity, the leader in Identity, Privacy, Governance and Exchange (IPGE) for real-world data, today announced the appointment of Joe Satili as Chief Commercial Officer and Don Ragas as Chief Data Officer. Satili brings two decades of sales and go-to-market experience with real-world data solutions for key Pharmaceutical Manufacturers while Ragas has successfully…